Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 11/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.82 |
| ▸ | HTT | P42858 | 1/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.82 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.82 |
| ▸ | MAOA | P21397 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.64 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.64 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.62 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11845043 | 0.94 | MAOB (0.82) | MAOBALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL42302 | 0.93 | MAOB (1.00) | MAOBALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL29154487 | 0.90 | ALDH1A1 (0.83) | MAOBALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL6054433 | 0.90 | MAOB (0.82) | MAOBALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL6337667 | 0.88 | MAOB (0.90) | MAOBALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL9126144 | 0.88 | MAOB (0.90) | MAOBALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL27518404 | 0.85 | MAOB (0.85) | MAOBALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL1750167 | 0.85 | NR4A2 (0.86) | ALDH1A1SMN1; SMN2MAPTNR4A1NR4A2 | |
| SCHEMBL17602370 | 0.84 | MAOB (0.82) | MAOBALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL933577 | 0.84 | MAOB (0.76) | MAOBALDH1A1HTTSMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220098159-A1 | CARBAMATE DERIVATIVES AND USES THEREOF | NodThera Limited (GB) | 2022-03-31 | — | — | US | disclosed |
| CN-113660983-A | Carbamate derivatives and uses thereof | 诺瑟拉有限公司 | 2021-11-16 | — | — | CN | disclosed |
| WO-2020152361-A1 | CARBAMATE DERIVATIVES AND USES THEREOF | NodThera Limited (GB) | 2020-07-30 | — | — | WO | disclosed |
| US-7646457-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-01-12 | — | — | US | disclosed |
| US-7646457-B2 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2010-01-12 | — | — | US | disclosed |
| US-20090109379-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM COPORATION (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20090109379-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM COPORATION (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20070259134-A1 | Cellulose Compound Film, Optical Compensation Sheet, Polarizing Plate, and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2007-11-08 | — | — | US | disclosed |
| US-20070259134-A1 | Cellulose Compound Film, Optical Compensation Sheet, Polarizing Plate, and Liquid Crystal Display Device | FUJIFILM CORPORATION (JP) | 2007-11-08 | — | — | US | disclosed |
| WO-2007111388-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2007-10-04 | — | — | WO | disclosed |
| US-20070182895-A1 | Liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070182895-A1 | Liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220098159-A1 | CARBAMATE DERIVATIVES AND USES THEREOF | CASP1, IL1B, PYCARD | MAOB 3295/4885ALDH1A1 617/4885HTT 4659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.